Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Comparative Performance of Robotic, Electromagnetic Navigation and Fluoroscopy Drives Optimal Diagnostic Strategy for Peripheral Pulmonary Lesions

NCT06701448 · Guangzhou Medical University · Updated 25 Nov 2024

What is being tested
robotic bronchosopy; Electromagnetic Navigation Bronchoscopy; Fluoroscopy bronchoscopy
For
Pulmonary Nodule; Bronchoscopy
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 75 years. About 342 people. The full rules are on the registry page.
Where
China
When
Starts or started 1 April 2019, ends 31 Dec 2023. Registered 22 Nov 2024.
Results
None posted yet.

In the researchers' words

Currently, the optimal method for Peripheral Pulmonary Lesions (PPL) is uncertain. We aim to compare the diagnostic yield of Robotic Bronchoscopy System (RBS), Electromagnetic Navigation Bronchoscopy (ENB), Fluoroscope-Bronchoscopy (FB).
ClinicalTrials.gov, NCT06701448

Sites

  • The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510163Guangzhou, Guangdong, China